1. ABOUT US

    #

    about us

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
  2. RESEARCH REPORTS

    RESEARCH REPORTS

    RESEARCH REPORTS

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
  3. METHODOLOGY

    #

    METHODOLOGY

    Azoth Analytics creates in-depth research reports by recording, interpreting and analyzing information through primary and secondary research. Our strategic market sizing and data dredging techniques include secondary research, interviews with key market players and industry experts and use of industry specific statistical tools which helps in designing and planning effective research for our global and local clients.

    Read More
  4. Consulting

    #

    Consulting

    Azoth Analytics Consulting assists clients across the globe to enter, progress, and develop in the targeted market through our fact-based business intelligence. We deliver practical and implementable solutions to our domestic and international clients. Our analysts are skilled with techniques of data gathering, market sizing, forecasting, analyzing and providing competitive intelligence and provide progressive research in verticals including healthcare & pharmaceutical...

    Read More
  5. media center

    #

    media center

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
news

     Home >> Research Report >> Healthcare & Pharma >> Global Liquid Biopsy Market: Analysis By Biomarkers (C-Tumor Cells, C-Tumor DNA, Vesicles), Cancer Type, By Product (Instruments, Reagents), By Region, By Country (2019 Edition): Opportunities and Forecast (2017-2024)
 

Global Liquid Biopsy Market: Analysis By Biomarkers (C-Tumor Cells, C-Tumor DNA, Vesicles), Cancer Type, By Product (Instruments, Reagents), By Region, By Country (2019 Edition): Opportunities and Forecast (2017-2024)-.

 
Publish Date:October 2019
No. of Pages:200
Format: Pdf (Instant Download)
 
 
Social
Electronic Access - Single User License toll
$1800
 
Electronic Access - Multi User License toll
$2400
 
Hard Copy Mail Delivery toll
$2000
 
 
Executive Summary

According to Azoth Analytics research report, the Liquid Biopsy was valued at USD 899.55 million for the year 2018. 

Over the recent years, Liquid Biopsy has been witnessing considerable growth on the back of growing focus on immunotherapy to cure cancer and shifting trend towards precision medicine along with high per capita healthcare expenditure and rapid adoption of novel diagnostic test by oncologist. Further, rising awareness for the early detection of cancer and sharp rise in its incidences have contributed to the growth rate of Liquid Biopsy Market. 

Among the Circulating Biomarker, Ct- DNA is the most used biomarker for the diagnosis in pre and post cancerous stage, as it provides more comprehensive overview of the tumor genomic status. Ongoing research and clinical trials suggest that exosomes and nucleosomes, will provide more efficient diagnostic results and hence market will be growing in the forecast period.

In the forecast period, continuous research and development by private manufacturers, government organizations and designated government labs along with growing number of clinical trials in liquid biopsy is anticipated to provide momentum to the market growth. However, generation of revenue from the liquid biopsy is dependent upon the interest of third party payers, hindering the market growth.

Scope of the Report

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Liquid Biopsy Market. The report analyses the Global Liquid Biopsy Market By Cancer Type (Lung, Breast, Colorectal, Prostate, Others), By Circulating Biomarker (Circulating tumor cells, ct-DNA, Vesicles) and By Product Type (Reagent, Instruments). The report analyzes the liquid biopsy market By Region (North America, Europe, APAC, ROW) and By Country (US, Germany, France, Japan) for the historical period of 2017 and 2018 and the forecast period of 2019-2024. 

Global Liquid Biopsy Market (Actual Period: 2017-2018, Forecast Period: 2019-2024)
• Liquid Biopsy Market: Size, Growth, Forecast
• Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
• Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
• Analysis By Product Type: Reagents, Instruments

Regional Liquid Biopsy Market - North America, Europe, APAC, ROW (Actual Period: 2017-2018, Forecast Period: 2019-2024)
• Liquid Biopsy Market: Size, Growth, Forecast
• Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
• Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
• Analysis By Product Type: Reagents, Instruments

Country Analysis – U.S., Germany, France, Japan (Actual Period: 2017-2018, Forecast Period: 2019-2024)
• Liquid Biopsy Market: Size, Growth, Forecast
• Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
• Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
• Analysis By Product Type: Reagents, Instruments

Other Report Highlights
• Competitive Landscape
• Leading Companies
• Investment and Partnerships
• Product Analysis
• Market Dynamics – Drivers and Restraints.
• Market Trends
• Porter Five Forces Analysis.
• SWOT Analysis.
• Company Analysis – Roche Diagnostics, Thermo Fisher Scientific, Guardant Health, Qiagen. 

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Liquid Biopsy Market: Product Outlook

5. Global Liquid Biopsy Market: Growth and Forecast (2017-2024)

6. Global Liquid Biopsy Market: Segment Analysis

6.1 Global Liquid Biopsy Market Size, By Cancer Type: Breakdown (%)
6.2 Global Lung Cancer Liquid Biopsy Market, By Value (2017-2024)
6.3 Global Breast Cancer Liquid Biopsy Market, By Value (2017-2024)
6.4 Global Colorectal Cancer Liquid Biopsy Market, By Value (2017-2024)
6.5 Global Prostate Cancer Liquid Biopsy Market, By Value (2017-2024)
6.6 Global Others Liquid Biopsy Market, By Value (2017-2024)
6.7 Market attractiveness of Global Liquid Biopsy Market- By Cancer Type
6.8 Global Liquid Biopsy Market  Size, By Circulating Biomarker: Breakdown (%)
6.9 Global CTC Liquid Biopsy Market, By Value (2017-2024)
6.10 Global ct-DNA Liquid Biopsy Market, By Value (2017-2024)
6.11 Global Vesicle Liquid Biopsy Market, By Value (2017-2024)
6.12 Market attractiveness of Global Liquid Biopsy Market- By Circulating Biomarker
6.13 Global Liquid Biopsy Market  Size, By Product Type: Breakdown (%)
6.14 Global Reagent Liquid Biopsy Market, By Value (2017-2024)
6.15 Global Instrument Liquid Biopsy Market, By Value (2017-2024)

7. Global Liquid Biopsy Market: Regional Analysis
7.1 Global Liquid Biopsy Market  Size, By Region : Breakdown (%)
7.1.1 Global Liquid Biopsy Market Size, By Region, 2024 (%)

7.2 North America Liquid Biopsy Market: Growth and Forecast
7.2.1 By Value (2017-2024)
7.2.2 By Cancer Type, By Value (2017-2024)
7.2.3 By Circulating Biomarker, By Value (2017-2024)
7.2.4 By Product Type, By Value (2017-2024)
7.3 North America Liquid Biopsy Market: Country Analysis (U.S)
7.3.1 U.S Liquid Biopsy Market, By Value (2017-2024)
7.3.2 U.S Liquid Biopsy Market, By Cancer Type, By Value (2017-2024)
7.3.3 U.S Liquid Biopsy Market, By Circulating Biomarker, By Value (2017-2024)
7.3.4 U.S Liquid Biopsy Market, By Product Type, By Value (2017-2024)

7.4 Europe Liquid Biopsy Market: Growth and Forecast
7.4.1 By Value (2017-2024)
7.4.2 By Cancer Type, By Value (2017-2024)
7.4.3 By Circulating Biomarker, By Value (2017-2024)
7.4.4 By Product Type, By Value (2017-2024)
7.5 Europe Liquid Biopsy Market: Country Analysis (Germany, France)
7.5.1 Germany Liquid Biopsy Market, By Value (2017-2024)
7.5.2 Germany Liquid Biopsy Market, By Cancer Type, By Value (2017-2024)
7.5.3 Germany Liquid Biopsy Market, By Circulating Biomarker, By Value (2017-2024)
7.5.4 Germany Liquid Biopsy Market, By Product Type, By Value (2017-2024)
7.5.5 France Liquid Biopsy Market, By Value (2017-2024)
7.5.6 France Liquid Biopsy Market, By Cancer Type, By Value (2017-2024)
7.5.7 France Liquid Biopsy Market, By Circulating Biomarker, By Value (2017-2024)
7.5.8 France Liquid Biopsy Market, By Product Type, By Value (2017-2024)

7.6 APAC Liquid Biopsy Market: Growth and Forecast
7.6.1 By Value (2017-2024)
7.6.2 By Cancer Type, By Value (2017-2024)
7.6.3 By Circulating Biomarker, By Value (2017-2024)
7.6.4 By Product Type, By Value (2017-2024)
7.7 APAC Liquid Biopsy Market: Country Analysis (Japan)
7.7.1 Japan Liquid Biopsy Market, By Value (2017-2024)
7.7.2 Japan Liquid Biopsy Market, By Cancer Type, By Value (2017-2024)
7.7.3 Japan Liquid Biopsy Market, By Circulating Biomarker, By Value (2017-2024)
7.7.4 Japan Liquid Biopsy Market, By Product Type, By Value (2017-2024)
7.8 ROW Liquid Biopsy Market: Growth and Forecast
7.8.1 By Value (2017-2024)
7.8.2 By Cancer Type, By Value (2017-2024)
7.8.3 By Circulating Biomarker, By Value (2017-2024)
7.8.4 By Product Type, By Value (2017-2024)

8. Global Liquid Biopsy Market: Competitive Landscape 
8.1 Market share of Leading Global Companies
8.2 Global Liquid Biopsy Market : Investments and Partnerships
8.3 Global Liquid Biopsy Market: Product Analysis

9. Global Liquid Biopsy Market Dynamics
9.1 Global Liquid Biopsy Market Drivers
9.1.1 Rising incidence of cancer
9.1.2 Growing focus on immunotherapy to cure cancer
9.1.3 Growing government expenditure in cancer research
9.2 Global Liquid Biopsy Market Restraints
9.2.1 Technology is dependent upon the interest shown by third party payers
9.3 Global Liquid Biopsy Market Trend
9.3.1 Adoption of precision medicine for curing cancer
9.3.2 Early detection of cancer

10. Porter's Five Forces Analysis

11. SWOT Analysis

12. Policy and Regulatory Landscape

13. Company Profiles
13.1 Guardant Health
13.2 Roche Diagnostics
13.3 Thermo Fisher Scientific
13.4 Qiagen


List of Figures

Figure 1:Global Liquid Biopsy Market Size, By Value, 2017-2024 (USD Million)
Figure 2:Potential opportunities of liquid biopsy across cancer continuum care
Figure 3:Key factors driving of change in the global oncology market
Figure 4:Value based payment models for cancer care
Figure 5:Biotechnology Research and Development Services Cost Index, In 2018 
Figure 6:Biopharmaceutical therapy selection market opportunity
Figure 7:Top 10 Most Frequent Cancer in Females, World, (Age-standardised incidence rate per 100,000) 
Figure 8:Top 10 Most Frequent Cancer Deaths in Females, World, (Age-standardised incidence rate per 100,000 women)
Figure 9:Global Prevalence of Different Type of Cancer, 2017 (In Thousands)
Figure 10:Global Prevalence of Prostate Cancer (2013-2017, Thousands)
Figure 11:Prevalence and Epidemiology of Cancer Worldwide
Figure 12:5 Year Survival Rate, Breast and Colorectal Cancer
Figure 13:Global Liquid Biopsy Market Size, By Type, 2024 (In %)
Figure 14:Global Lung Cancer Market, By Value, Forecast, 2019-2024 (USD Million)
Figure 15:Global Breast Cancer Market, By Value, Forecast, 2019-2024 (USD Million)
Figure 16:Global Colorectal Cancer Market, By Value, Forecast, 2019-2024 (USD Million)
Figure 17:Global  Prostate Cancer Market, By Value, Forecast, 2019-2024 (USD Million)
Figure 18:Global Other Cancer Market, By Value, Forecast, 2019-2024 (USD Million)
Figure 19:Market Opportunity Chart of Global Liquid Biopsy Market – By Cancer Type, By Value (Year - 2024)
Figure 20:Global Liquid Biopsy Market Size, By Type, 2024 (In %)
Figure 21:Global CTC Biomarker Liquid Biopsy Market, By Value, Forecast, 2019-2024 (USD Million)
Figure 22:Global ct-DNA Biomarker Liquid Biopsy Market, By Value, Forecast, 2019-2024 (USD Million)
Figure 23:Global Vesicles Biomarker Liquid Biopsy Market, By Value, Forecast, 2019-2024 (USD Million)
Figure 24:Market Opportunity Chart of Global Liquid Biopsy Market - By Circulating Biomarker, By Value (Year - 2024)
Figure 25:Global Liquid Biopsy Market Size, By Type, 2024 (In %)
Figure 26:Global Reagent Liquid Biopsy Market, By Value, Forecast, 2019-2024 (USD Million)
Figure 27:Global Instrument Liquid Biopsy Market, By Value, Forecast, 2019-2024 (USD Million)
Figure 28:Market Opportunity Chart of Global Liquid Biopsy Market - By Product Type, By Value (Year - 2024)
Figure 29:Global Healthcare Landscape, By Select Region
Figure 30:Global Liquid Biopsy Market  Size, By Region, 2024 (%)
Figure 31:North America Liquid Biopsy Market Size, By Value, 2017-2024 (USD Million)
Figure 32:North America GDP, 2012-2017 (USD Trillion)
Figure 33: North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 34:Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds)
Figure 35:North America, Cancer Incidence (In Millions)
Figure 36:North America, Cancer Incidence, 2019 (In %)
Figure 37:North America, Cancer Incidence, 2019 (In %)
Figure 38:North America GDP, 2012-2017 (USD Trillion)
Figure 39:North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 40:North America Liquid Biopsy Market: By Cancer Type, By Value, 2017-2024 (USD Million)
Figure 41:North America Liquid Biopsy Market: By Circulating Biomarker, By Value, 2017-2024 (USD Million)
Figure 42:North America Liquid Biopsy Market: By Product Type, By Value, 2017-2024 (USD Million)
Figure 43:USA Liquid Biopsy Market, By Value, 2017-2024 (USD Million)
Figure 44:Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)
Figure 45:Leading Sites of New Cancer Cases in the United States amongst Females, 2018 (In %)
Figure 46:Estimated New Cases of Cancer in the United States, By  Type 2018 (In %)
Figure 47:Estimated New Cases of Cancer in the United States, 2014-2018 (In Thousands)
Figure 48:Estimated New Cases of Cancer in the United States, By State, 2018
Figure 49: Percentage of adults aged 18-64 with insurance coverage in United States, By Poverty status, In 2018 
Figure 50:Percentage of individuals with insurance coverage in United States, By Age Group, In 2018 
Figure 51:Medical and Healthcare Research & Development Spending, 2014-2017 (In USD Million) 
Figure 52:Research and Development Expenditure of total U.S. Pharmaceutical Industry, 2013-2017, (USD Billion) 
Figure 53:US Liquid Biopsy Market: By Cancer Type, By Value, 2017-2024 (USD Million)
Figure 54:US Liquid Biopsy Market: By Cancer Type, By Value, 2017-2024 (USD Million)
Figure 55:US Liquid Biopsy Market: By Product Type, By Value, 2017-2024 (USD Million)
Figure 56:Europe Liquid Biopsy Market Size, By Value, 2017-2024 (USD Million)
Figure 57:Europe, Cancer Incidence, 2019E-2035F (In Millions)
Figure 58:Europe, Cancer Incidence, By Type, 2019E
Figure 59:Prevalence of Different Type of Cancer in Western Europe in year 2016 & 2017 ( In Thousands)
Figure 60:Europe, Per Capita Health Expenditure, By Select Country, 2017 (USD) 
Figure 61:GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
Figure 62:Europe Liquid Biopsy Market: By Cancer Type, By Value, 2017-2024 (USD Million)
Figure 63:Europe Liquid Biopsy Market: By Circulating Biomarker, By Value, 2017-2024 (USD Million)
Figure 64:Europe Liquid Biopsy Market: By Product Type, By Value, 2017-2024 (USD Million)
Figure 65: Germany Liquid Biopsy Market, By Value, 2017-2024 (USD Million)
Figure 66:Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 67:Prevalence of Different Type of Cancer in Germany in year 2016 & 2017 ( In Hundreds)
Figure 68:German Pharmaceutical companies expenditure on  R&D, In Million Euros
Figure 69:Germany, Population ages 65 and above, 2012-2018 (% total)
Figure 70:Germany Liquid Biopsy Market: By Cancer Type, By Value, 2017-2024 (USD Million)
Figure 71:Germany  Liquid Biopsy Market: By Circulating Biomarker, By Value, 2017-2024 (USD Million)
Figure 72:Germany Liquid Biopsy Market: By Product Type, By Value, 2017-2024 (USD Million)
Figure 73:France Liquid Biopsy Market, By Value, 2017-2024 (USD Million)
Figure 74:France, Number of Biotech Companies, By Type, 2017
Figure 75:France, Prevalence of Cancer, 2018, (% of total)
Figure 76:Healthcare expenditure in France ( as a % of GDP)
Figure 77:Healthcare spending pattern in France, In 2016 & 2050, In USD $
Figure 78:France Liquid Biopsy Market: By Cancer Type, By Value, 2017-2024 (USD Million)
Figure 79:France Liquid Biopsy Market: By Cancer Type, By Value, 2017-2024 (USD Million)
Figure 80:France Liquid Biopsy Market: By Product Type, By Value, 2017-2024 (USD Million)
Figure 81: APAC Liquid Biopsy Market Size, By Value, 2017-2024 (USD Million)
Figure 82:Estimated number of deaths from prostate cancer in 2012 and 2030
Figure 83:World health expenditure as % of GDP
Figure 84:Population ages 65 and above, APAC Region, By Select Countries, 2017 (% of total) 
Figure 85:Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total) 
Figure 86:APAC, GDP, By Select Country, 2017 (In USD Trillion)
Figure 87:APAC Liquid Biopsy Market: By Cancer Type, By Value, 2017-2024 (USD Million)
Figure 88:APAC Liquid Biopsy Market: By Circulating Biomarker, By Value, 2017-2024 (USD Million)
Figure 89:APAC Liquid Biopsy Market: By Product Type, By Value, 2017-2024 (USD Million)
Figure 90:Japan Liquid Biopsy Market, By Value, 2017-2024 (USD Million)
Figure 91:Japan, Cancer Prevalence, By Type, (2018)
Figure 92:Proportional mortality in Japan, In 2018
Figure 93:Japan, GDP Growth Per Year, 2015-2019F (In %)
Figure 94:Japan, Population ages 65 and above, 2012-2018 (% of total)
Figure 95:Japan Liquid Biopsy Market: By Cancer Type, By Value, 2017-2024 (USD Million)
Figure 96:Japan Liquid Biopsy Market: By Circulating Biomarker, By Value, 2017-2024 (USD Million)
Figure 97: Japan Liquid Biopsy Market: By Product Type, By Value, 2017-2024 (USD Million)
Figure 98:ROW Liquid Biopsy Market Size, By Value, 2017-2024 (USD Million)
Figure 99:Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
Figure 100:Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
Figure 101:Prevalence of Different Type of Cancer in Middle East and North Africa  in year 2016 & 2017 ( In Hundreds)
Figure 102:Prevalence of Different Type of Cancer in Brazil  in year 2016 & 2017 ( In Hundreds)
Figure 103:Population ages 65 and above, By Select Country, 2017 (% of total) 
Figure 104:Population ages 60 and above, By Select Country, 2050 (% of total) 
Figure 105:ROW Liquid Biopsy Market: By Cancer Type, By Value, 2017-2024 (USD Million)
Figure 106:ROW Liquid Biopsy Market: By Circulating Biomarker, By Value, 2017-2024 (USD Million)
Figure 107:ROW Liquid Biopsy Market: By Product Type, By Value, 2017-2024 (USD Million)
Figure 108:Global Liquid Biopsy Market Share, By Select Company, 2018 (In %)
Figure 109:Guardant Health, Sales Revenue, 2016-2018 (USD Million) 
Figure 110:Guardant Health, Sales Revenue, By Segment, In 2018 (USD Million) 
Figure 111:Roche Diagnostics, Sales Revenue, 2014-2018 (USD Million) 
Figure 112:Roche Diagnostics, Sales Revenue, By Diagnostic Segment, In 2018 (USD Million)
Figure 113: Roche Diagnostics, Molecular Diagnostics Sales Revenue, By Geographical Segment, In 2018 (USD Million) 
Figure 114:Thermo Fisher Scientific, Sales Revenue, 2014-2018 (USD Million) 
Figure 115:Thermo Fisher Scientific, Sales Revenue, By Business Segment, In 2018 (USD Million) 
Figure 116:Thermo Fisher Scientific, Sales Revenue, By Geographical Segment, In 2018 (USD Million) 
Figure 117:Qiagen, Sales Revenue, 2014-2018 (USD Million) 
Figure 118:Qiagen, Sales Revenue, By Business Segment, In 2018 (USD Million) 
Figure 119:Qiagen, Sales Revenue, By Geographical Segment, In 2018 (USD Million)

List of Tables

Table A:Estimated Numbers of US Cancer Survivors (As of January 1, 2016)
Table B:Estimated Numbers of US Cancer Survivors (As of January 1, 2026F)
Table C:Germany, Healthcare Related Statistics, 2017
Table D:Recent Investments and Partnerships in Liquid Biopsy Market
Table E:Liquid Biopsy assays using c- tumor cells, as yet
Table F:Liquid Biopsy assays using circulating free DNA, as yet
Table G:Ongoing clinical trials in ct- DNA liquid biopsy
Table H:Ongoing clinical trials in CTC liquid biopsy

One can also purchase any particular sections from this report. Please send us an email to info@azothanalytics.com with your order details.
 
 
 
 
 Latest Market Research Reports